Clinical Trial Update: Patients With Intermittent Claudication Injected With ALDH Bright Cells [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ALDH Bright Cells for Peripheral Artery Disease has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• ALDH Bright Cells

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Peripheral Artery Disease, Intermittent Claudication | Phase 2 | Status: COMPLETED | Results posted: 2017-04-21